Skip to main content
CAR T-cell Immunotherapy Plays Important Role in Hard-to-Treat Lymphoma
Health Insight
A Mediaplanet Content Hub
Advocacy
Managing Illnesses
Innovations
Wellness
More
Advancements in Women's Health
Chronic Conditions
Exploring the Gut & Microbiome
Heart Health
Improving Accessibility in Canada
Managing Diabetes
Men's Cancers
Mental Health
Patient Access & Health Equity
Rare Disease
Sexual & Reproductive Health
Supporting Canadian Caregivers
Understanding Neurological Conditions
Women's Health Care
Pathways to Parenthood
Advancements in Women's Health
Chronic Conditions
Exploring the Gut & Microbiome
Heart Health
Improving Accessibility in Canada
Managing Diabetes
Men's Cancers
Mental Health
Patient Access & Health Equity
Rare Disease
Sexual & Reproductive Health
Supporting Canadian Caregivers
Understanding Neurological Conditions
Women's Health Care
Pathways to Parenthood
leukemia
Immunotherapy
CAR T-cell Immunotherapy Plays Important Role in Hard-to-Treat Lymphoma
For people with certain types of lymphomas, CAR T-cell therapy is becoming an important option for patients who have had at least two lines of prior treatment.